Ledipasvir
Who holds supplier records for Ledipasvir? 1 organisation holds a current record for Ledipasvir: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Ledipasvir: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/ledipasvir
Reading the evidence
- One current record
One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (1)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ledipasvir. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 33430 · latest filing Dec 2018
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Ledipasvir are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- India · Inactive DMF 34446 · filed Dec 2019
Overview
Ledipasvir is a direct-acting antiviral agent used in combination with sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection. It works by inhibiting the HCV NS5A protein, which is essential for viral replication.
Chemical identity
- IUPAC name
- methyl N-[(2S)-1-[(6S)-6-[5-[9,9-difluoro-7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzimidazol-5-yl]fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptan-5-yl]-3-methyl-1-oxobutan-2-yl]carbamate
- Canonical SMILES
- CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
- InChIKey
- VRTWBAAJJOHBQU-KMWAZVGDSA-N
- Synonyms
- gs-5885, harvoni component ledipasvir, ledipasvir acetonate
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ledipasvir?
1 organisation holds an active US FDA Type II Drug Master File or a CEP for Ledipasvir: MATRIX PHARMACORP PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ledipasvir Drug Master Files are active?
MATRIX PHARMACORP PRIVATE LTD (DMF 33430). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ledipasvir records mean?
1 organisation has only inactive Type II DMFs for Ledipasvir. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Ledipasvir supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ledipasvir?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.